Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
117,400
-13,000 (-9.97%)
At close: Oct 24, 2025
-9.97%
Market Cap1.10T
Revenue (ttm)521.50B
Net Income (ttm)62.57B
Shares Out9.33M
EPS (ttm)6,704.93
PE Ratio17.51
Forward PEn/a
Dividend2,400.00 (2.04%)
Ex-Dividend DateSep 9, 2025
Volume2,462
Average Volume3,824
Open134,500
Previous Close130,400
Day's Range117,400 - 143,400
52-Week Range96,000 - 143,400
Beta-0.30
RSI54.41
Earnings DateJan 19, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 535
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2024, HNX:PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 58.50 billion, a decrease of -4.11%.

Financial Statements

News

There is no news available yet.